TotalMarketCap

Vor Biopharma

VORNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.148 B

$18.69 -7.11%

Close of 6 Nov 2026

As of 6 Nov 2026, Vor Biopharma (VOR) has a market capitalization of $1.15B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$696.0M

Loss-making

Shares outstanding

61,434,344

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #43Taysha Gene TherapiesTSHA$1.35B
  2. #44Inhibrx BiosciencesINBX$1.18B
  3. #45Vor BiopharmaVOR$1.15B
  4. #46ImmaticsIMTX$930.0M
  5. #47Odyssey TherapeuticsODTX$904.9M

What if Vor Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$459,626.85

Per share 24,592× higher

Bitcoin $1.53T

$24,869.61

Per share 1,331× higher

Apple $5.02T

$81,644.60

Per share 4,368× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Vor Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.